Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)
2022 · BMC Cancer · 11 citations
https://doi.org/10.1186/s12885-022-09611-3
S
Shigeki Kataoka
Kyoto University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
313
Citations
7
h-index
6
i10-index
Shigeki Kataoka is an academic researcher from Kyoto University. The author has contributed to research in topics: Renal cell carcinoma treatment & Helicobacter pylori-related gastroenterology studies & Pancreatic and Hepatic Oncology Research. The author has an h-index of 7, co-authored 36 publications.
ORCID: 0000-0002-1072-8367Papers by this author
worksCancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report
2020 · BMC Cancer · 10 citations
https://doi.org/10.1186/s12885-020-07640-4
Additional file 1 of Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13324133
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)
2025 · Journal of Gastroenterology · 0 citations
https://doi.org/10.1007/s00535-025-02294-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat